Clinical Trial Update: Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program

View source ↗

Summary

A completed clinical trial assessing the real-life effectiveness of the Kaletra Adherence Support Assistance (KASA) program for HIV infection, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Human Immunodeficiency Virus Infection | Status: COMPLETED | Results posted: 2018-01-29